Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients*
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The role of intensive insulin therapy in medical surgical intensive care patients remains unclear. The objective of this study was to examine the effect of intensive insulin therapy on mortality in medical surgical intensive care unit patients. DESIGN: Randomized controlled trial. SETTINGS: Tertiary care intensive care unit. PATIENTS: Medical surgical intensive care unit patients with admission blood glucose of > 6.1 mmol/L or 110 mg/dL. INTERVENTION: A total of 523 patients were randomly assigned to receive intensive insulin therapy (target blood glucose 4.4-6.1 mmol/L or 80-110 mg/dL) or conventional insulin therapy (target blood glucose 10-11.1 mmol/L or 180-200 mg/dL). MEASUREMENTS AND MAIN OUTCOMES: The primary end point was intensive care unit mortality. Secondary end points included hospital mortality, intensive care unit and hospital length of stay, mechanical ventilation duration, the need for renal replacement therapy and packed red blood cells transfusion, and the rates of intensive care unit acquired infections as well as the rate of hypoglycemia (defined as blood glucose < or = 2.2 mmol/L or 40 mg/dL). There was no significant difference in intensive care unit mortality between the intensive insulin therapy and conventional insulin therapy groups (13.5% vs. 17.1%, p = 0.30). After adjustment for baseline characteristics, intensive insulin therapy was not associated with mortality difference (adjusted hazard ratio 1.09, 95% confidence interval 0.70-1.72). Hypoglycemia occurred more frequently with intensive insulin therapy (28.6% vs. 3.1% of patients; p < 0.0001 or 6.8/100 treatment days vs. 0.4/100 treatment days; p < 0.0001). There was no difference between the intensive insulin therapy and conventional insulin therapy in any of the other secondary end points. CONCLUSIONS: Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia. Based on these results, we do not advocate universal application of intensive insulin therapy in intensive care unit patients. TRIAL REGISTRATION: Current Controlled Trials registry (ISRCTN07413772) http://www.controlled-trials.com/ISRCTN07413772/07413772; 2005.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overall rate of severe hypoglycemic events in international trials ranged between 5% to 28.6%.3,4,7,8,18,19”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [18]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664 · cited 2×
“nonoperative), history of diabetes, inclusion blood glucose, ICU admission diagnosis and the presence of chronic illnesses using APACHE II definitions (15), vasopressor therapy (defined as the use of any vasopressor infusion except dopamine 5 g/ kg/min), mechanical ventilation, serum creatinine, platelet count, biliru…”
MethodAPACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“At baseline the following data were recorded: patient’s demographics, weight, height, body mass index (BMI), Acute Physiology and Chronic Health Evaluation (APACHE) II score (15), Sequential Organ Failure Assessment (SOFA) score (16), admission category (postoperative vs.”
MethodPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Insulin therapy protects the central and peripheral nervous system of intensive care patients
Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., & Wouters, P. J. (2005) · Neurology · doi:10.1212/01.wnl.0000158442.08857.fc · Cited by 642 · cited 1×
“found that IIT reduced ventilation dependency, intracranial pressure, seizures, and diabetes insipidus, but did not affect mortality (27).”
Background
Research works printed but not linked: 2
- Orford, 2006, Crit Care Resusc, 8, 230
- Devos, 2007, Intensive care Med, 33, S189
Cited by
Items 101–200 of 466
Schierenbeck, F., Öwall, A., Franco‐Cereceda, A., & Liška, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0169 · Cited by 45
Kalfon, P., Le Manach, Y., Ichai, C., Bréchot, N., Cinotti, R., Dequin, P.-F., Riu-Poulenc, B., Montravers, P., Annane, D., Dupont, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0851-7 · Cited by 45
“previously observed [11,13,14,17,28,31], we observed a dose–response relationship as severe hypoglycemia was associated with higher rates of death than was moderate hypoglycemia or the occurrence of multiple hypoglycemic events.”
BackgroundWernly, B., Lichtenauer, M., Hoppe, U. C., & Jung, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.24 · Cited by 47
“In a summary of five studies (15,18-21) comparing tight glucose control (blood glucose between 80–110 mg/dL) to control groups, an increased risk of death was reported for intensive insulin therapy and the control group showed better survival (OR 0.”
BackgroundUpdate on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 58
“Two other singlecenter studies found no decrease in mortality and morbidity in medical and surgical ICU patients receiving IIT [21,22].”
BackgroundInfluentialGlycemic control in the intensive care unit: A control systems perspective
Chase, J. G., Benyó, B. I., & Desaive, T. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.03.007 · Cited by 50
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Hiperglucemia de estrés y su control con insulina en el paciente crítico: evidencia actual
Manzanares, W., & Aramendi, I. (2009) · Medicina Intensiva · doi:10.1016/j.medin.2009.10.003 · Cited by 66
Mirabile, A., Numico, G., Russi, E. G., Bossi, P., Crippa, F., Bacigalupo, A., Sanctis, V. D., Musso, S., Merlotti, A. M., Ghi, M. G., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.03.003 · Cited by 43
“[177] Arabi YM, Dabbagh OC, Tamim HM, et al.”
BackgroundHyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
Becker, C. D., Sabang, R. L., Cordeiro, M. F. N., Hassan, I. F., Goldberg, M. D., & Scurlock, C. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.012 · Cited by 43
Matsushima, K., Peng, M., Velasco, C., Schaefer, É., Diaz-Arrastia, R. R., & Frankel, H. L. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.08.012 · Cited by 72
“We could achieve relatively lower incidence of severe hypoglycemia (b40 mg/dL) in our study compared with prior prospective studies using the implementation of strict protocol with experienced critical care nursing staff [16,36].”
ResultHua, J., Chen, G., Li, H., Fu, S., Zhang, L., Scott, M., & Li, Q. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2011.12.016 · Cited by 43
Krinsley, J. S., & Fisher, M. C. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.967 · Cited by 43
Krinsley, J. S., Bruns, D. E., & Boyd, J. C. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814566507 · Cited by 41
“Analytic inaccuracies associated with meter-based technologies, used in some studies, have been well described;7-9 other authors have described strengths and limitations of blood gas analyzers used for BG monitoring in the critically ill.10-14 Low frequency of BG monitoring undoubtedly also contributed to the lower th…”
InfluentialEffects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis
Kang, Z.-Q., Huo, J.-L., & Zhai, X. (2018) · Endocrine Connections · doi:10.1530/ec-18-0231 · Cited by 47
Early immune system alterations in patients with septic shock
Tang, H., Qin, S., Li, Z., Gao, W., Tang, M., & Dong, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126874 · Cited by 41
Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
Krinsley, J. S. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1066227 · Cited by 43
“6% [5] experienced at least one episode of severe hypoglycemia (BG <40 mg/dL) associated with IIT.”
van Hooijdonk, R. T. M., Leopold, J. H., Winters, T., Binnekade, J. M., Juffermans, N. P., Horn, J., Fischer, J., van Dongen-Lases, E. C., & Schultz, M. J. (2015) · Critical Care · doi:10.1186/s13054-015-0757-4 · Cited by 46
“Continuous glucose monitoring (CGM) is suggested to increase practicalities and safety of insulin titration in ICU patients [1,4], in particular when targeting normal or near-normal blood glucose levels when hypoglycemic episodes can be expected [5-13].”
BackgroundGlycemic Control in the Medical Intensive Care Unit
Kovalaske, M. A., & Gandhi, G. Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300613 · Cited by 47
Critical Care Management of Stress-Induced Hyperglycemia
Vanhorebeek, I., Gunst, J., & den Berghe, G. V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0988-2 · Cited by 43
NICE-SUGAR: the end of a sweet dream?
Preiser, J. (2009) · Critical Care · doi:10.1186/cc7790 · Cited by 40
“Several investigators [3-6] and the Leuven medical ICU team [7] had already assessed the effects of TGCIIT in various settings and conditions.”
BackgroundResultManagement of Hyperglycemia During the Perioperative Period
Pichardo-Lowden, A. R., & Gabbay, R. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0239-2 · Cited by 39
Accuracy of Blood Glucose Measurement and Blood Glucose Targets
Eerdekens, G.-J., Rex, S., & Mesotten, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905581 · Cited by 46
Yuan, J., Liu, T., Zhang, X., Si, Y., Ye, Y., Zhao, C., Wang, Q., & Shen, X. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2871-7 · Cited by 39
“Although intensive glycemic control has been reported to reduce morbidity and mortality rates in critical ill and surgical patients,(1) , 10 other trials did not confirm these results, indicating that intensive glycemic control increased the rates of hypoglycemia and mortality.(11) –13 Our study found that the surgica…”
ResultClinical benefits of tight glycaemic control: focus on the intensive care unit
Mesotten, D., & den Berghe, G. V. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.08.006 · Cited by 39
Intensive insulin therapy for septic patients: A meta-analysis of randomized controlled trials.
Song, F., Zhong, L.-J., Han, L., Xie, G.-H., Xiao, C., Zhao, B., Hu, Y.-Q., Wang, S.-Y., Qin, C.-J., Zhang, Y., et al. (2014) · BioMed Research International · doi:10.1155/2014/698265 · Cited by 35
“Through performing several sensitivity analyses (the trials with “low risk” of “random sequence generation” and “allocation concealment”, the trials with>500 patients, the trials with septic shock data, and studies with excluding unclear baseline characteristics) [17, 23, 24], the overall effect size was found to chan…”
BackgroundInfluentialAbdelmalak, B., & Lansang, M. C. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2012.09.006 · Cited by 41
“Compounding the problem, tight glycemic control is associated with an incidence of hypoglycemia [3,5–7] and such hypoglycemic episodes may offset some of the potential”
BackgroundOptimal Glucose Management in the Perioperative Period
Evans, C. H., Lee, J., & Ruhlman, M. K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.11.003 · Cited by 43
Optimal Caloric Intake for Critically Ill Patients: First, Do No Harm
Dickerson, R. N. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533610393254 · Cited by 35
van Steen, S. C. J., Rijkenberg, S., Sechterberger, M. K., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1045 · Cited by 36
Hyperglycaemia in critically ill patients: the immune system’s sweet tooth
van Niekerk, G., Davis, T., & Engelbrecht, A. (2017) · Critical Care · doi:10.1186/s13054-017-1775-1 · Cited by 38
Gerganova, A., Assyov, Y. S., & Kamenov, Z. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.826006 · Cited by 39
Zetterling, M., Hillered, L., Enblad, P., Karlsson, T., & Ronne-Engström, E. (2011) · Journal of neurosurgery · doi:10.3171/2011.3.jns10899 · Cited by 38
The Place for Glycemic Control in the Surgical Patient
May, A. K., Kauffmann, R. M., & Collier, B. R. (2011) · Surgical Infections · doi:10.1089/sur.2011.019 · Cited by 37
“Studies of glycemic control have been performed in both the peri-operative and ICU settings, although the majority have been studies of both surgical and non-surgical ICU populations [1,6-10,21,72-74], with a smaller number of studies focused specifically on the peri-operative setting, nearly all of which are in the s…”
InfluentialSathishkumar, S., Lai, M., Picton, P., Kheterpal, S., Morris, M., Shanks, A. M., & Ramachandran, S. K. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000699 · Cited by 33
“647 Emergent procedure 284 (18) 99 (13) 2,341 100 <0.”
Management of critically ill patients with type 2 diabetes: The need for personalised therapy
Kar, P., Jones, K. L., Horowitz, M., & Deane, A. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.693 · Cited by 37
Global Collaboration in Acute Care Clinical Research: Opportunities, Challenges, and Needs
Marshall, J. C. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002211 · Cited by 36
Shah, F. A., Mahmud, H., Gallego‐Martin, T., Jurczak, M. J., O'Donnell, C. P., & McVerry, B. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00296 · Cited by 33
Impact of a computer-generated alert system on the quality of tight glycemic control
Meyfroidt, G., Wouters, P. J., Becker, W. D., Cottem, D., & den Berghe, G. V. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2159-7 · Cited by 31
“However, although it remains unclear whether brief episodes of hypoglycemia in the context of tight glycemic control causes damage [7], a reduced number of patients who experience hypoglycemia is an important safety asset for clinicians.”
BackgroundThe role of hyperglycemia in acute illness: Supporting evidence and its limitations
Corathers, S. D., & Falciglia, M. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.013 · Cited by 37
Dysglycemia in the critically ill patient: current evidence and future perspectives
Aramendi, I., Burghi, G., & Manzanares, W. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170054 · Cited by 38
Rijkenberg, S., van Steen, S. C. J., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-017-0086-z · Cited by 31
Uyttendaele, V., Knopp, J. L., Davidson, S. M., Desaive, T., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0720-8 · Cited by 31
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 37
Westphal, G. A., Filho, M. C., Vieira, K. D., Zaclikevis, V. R., Bartz, M. C. M., Wanzuita, R., Réa-Neto, Á., Teixeira, C., Franke, C. A., Machado, F. O., et al. (2011) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2011000300004 · Cited by 48
Insulin therapy in critically ill patients
Ellahham, S. H. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14203 · Cited by 35
Watkinson, P., Barber, V. S., Amira, E., James, T., Taylor, R. P., & Young, J. D. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011162 · Cited by 32
Preechasuk, L., Suwansaksri, N., Ipichart, N., Vannasaeng, S., Permpikul, C., & Sriwijitkamol, A. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.12.005 · Cited by 33
“Despite this association between sepsis severity and hyperglycemia, studies [3-9] that have aimed to normalize glucose levels have shown inconclusive findings on sepsis outcomes.”
BackgroundRelative accuracy of arterial and capillary glucose meter measurements in critically ill patients
Lonjaret, L., Claverie, V., Bérard, E., Riu-Poulenc, B., Geeraerts, T., Genestal, M., & Fourcade, O. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.12.003 · Cited by 29
Hsu, C.-W., Sun, S., Lin, S.-L., Huang, H.-H., & Wong, K.-F. (2012) · Critical Care · doi:10.1186/cc11299 · Cited by 31
“However, some studies failed to demonstrate improved outcome [9-12], and even a higher mortality rate was found [13] Intensive insulin therapy has been associated with a significantly higher risk of hypoglycemia [5,7], resulting in concern regarding the safety of intensive insulin therapy.”
ResultMeng, J., Li, X., Xiao, Y., Tang, H., Liu, P., Wu, Y., Xiong, Y., & Gao, S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103045 · Cited by 29
Evaluation of a Continuous Blood Glucose Monitoring System Using Central Venous Microdialysis
Schierenbeck, F., Franco‐Cereceda, A., & Liška, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600615 · Cited by 34
Evaluation of Compliance with a Paper-based, Multiplication-factor, Intravenous Insulin Protocol
Cyrus, R. M., Szumita, P. M., Greenwood, B. C., & Pendergrass, M. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m060 · Cited by 30
Insights into the Roles of B Cells in Patients with Sepsis
Dong, X., Tu, H., Qin, S., Bai, X., Yang, F., & Li, Z. (2023) · Journal of Immunology Research · doi:10.1155/2023/7408967 · Cited by 31
“Although intravenous IgG-only polyclonal immunoglobulin has been suggested to treat sepsis, it has not been proven beneficial [119, 122], even in a large study (n= 624) [123].”
BackgroundDiabetes, dysglycemia, and vascular surgery
Duwayri, Y. M., & Jordan, W. D. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.05.027 · Cited by 31
How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?
Wahl, H. G. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.09.003 · Cited by 32
Matias, C. D. N., de Lima, V. C. C., Teixeira, H. M., Souto, F. R., & Magalhães, V. (2013) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20130013 · Cited by 28
“However, a recent large-scale randomized trial indicated that such glycemic control is not effective in reducing ICU mortality and that glycemic control with intensive insulin therapy increases the risk of hypoglycemia and complications arising from hypoglycemia(8).”
ResultSong, I., Lee, J., Kang, J.-E., Park, Y.-H., Kim, H., & Kim, J. (2015) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-015-9804-6 · Cited by 26
Lin, K., Shang, X., Guo, Y., Zhu, P.-L., Wu, Z.-Y., Jiang, H., Ruan, J., Zheng, W.-P., You, Z., & Lin, C.-J. (2018) · Angiology · doi:10.1177/0003319718758140 · Cited by 28
Glycemic targets in critically ill adults: A mini-review
See, K. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1719 · Cited by 28
Perioperative glycemic management in 2011: paradigm shifts
Maerz, L. L., & Akhtar, S. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328348beb7 · Cited by 32
Pérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2016) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.10.026 · Cited by 33
Fitzgerald, O., Perez‐Concha, O., Gallego, B., Saxena, M. K., Rudd, L., Metke‐Jimenez, A., & Jorm, L. R. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab060 · Cited by 27
Perioperative glycaemic control for people with diabetes undergoing surgery
Bellon, F., Solà, I., Giménez‐Pérez, G., Hernández, M., Metzendorf, M., Rubinat, E., & Mauricio, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub3 · Cited by 49
A patient-level meta-analysis of intensive glucose control in critically ill adults
Adigbli, D., Li, Y., Hammond, N., Chatoor, R., Devaux, A. G., Li, Q., Billot, L., Annane, D., Arabi, Y., Bilotta, F., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400082 · Cited by 25
Self-citationFogel, S. L., & Baker, C. C. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.12.015 · Cited by 24
“Although tighter glycemic control is becoming the standard of care, it might be associated with hypoglycemia and increased workloads for those managing the blood glucose.(6,7) In 2011, the American College of Physicians released practice guidelines that stated that the use of intensive insulin therapy (IIT) was associ…”
BackgroundAssessing Inpatient Glycemic Control: What are the Next Steps?
Cook, C. B., Wellik, K. E., Kongable, G. L., & Shu, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600230 · Cited by 28
Blood Glucose Control Among Critically Ill Patients with Brain Injury
Jacka, M. J., Torok-Both, C. J., & Bagshaw, S. M. (2009) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100007757 · Cited by 28
Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2019) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2019.100063 · Cited by 25
Merz, T. M., & Finfer, S. R. (2008) · Critical Care · doi:10.1186/cc6837 · Cited by 28
Clinical challenges of glycemic control in the intensive care unit: A narrative review
Sreedharan, R., Martini, A., Das, G., Aftab, N., Khanna, S. K., & Ruetzler, K. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11260 · Cited by 26
Boussekey, N., Cantrel, J., Debrabant, L. D., Langlois, J., Devos, P., Meybeck, A., Chiche, A., Georges, H., & Leroy, O. (2010) · Critical Care Research and Practice · doi:10.1155/2010/436427 · Cited by 23
“The same team [28] did not confirm their results in a population of medical patients and the study recently published by Arabi do not support this intensive strategy [29].”
ResultHonarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006173 · Cited by 22
Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes
Balintescu, A., & Mårtensson, J. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.010 · Cited by 22
Sepsis in pregnancy and early goal-directed therapy
Joseph, J. T., Sinha, A., Paech, M. J., & Walters, B. N. J. (2009) · Obstetric Medicine · doi:10.1258/om.2009.090024 · Cited by 23
What is the optimal blood glucose target in critically ill patients? A nested cohort study
Arabi, Y. M., Al-Tarifi, A., Abou‐Shala, N., Tamim, H., & Rishu, A. (2011) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.84774 · Cited by 22
“However, several subsequent randomized controlled trials targeting similar BG levels [10-14] showed no mortality benefit but a significant risk of hypoglycemia with IIT.”
Self-citationGlycemic control in cardiac surgery: Rationale and current evidence
Girish, G., Agarwal, S., Satsangi, D. K., Tempe, D. K., Dutta, N., & Pratap, H. (2014) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.135873 · Cited by 22
Mita, N., Kawahito, S., Soga, T., Takaishi, K., Kitahata, H., Matsuhisa, M., Shimada, M., Kinoshita, H., Tsutsumi, Y. M., & Tanaka, K. (2016) · Journal of Artificial Organs · doi:10.1007/s10047-016-0925-6 · Cited by 21
Umpierrez, G. E. (2023) · New England Journal of Medicine · doi:10.1056/nejme2309442 · Cited by 21
Agus, M. S. D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V. S., Luckett, P. M., Curley, M. A. Q., Alexander, J. L., Asaro, L. A., Coughlin-Wells, K., Duva, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.023 · Cited by 20
Zhu, C., Chen, J., Pan, J., Qiu, Z., & Xu, T. (2018) · Medicine · doi:10.1097/md.0000000000011671 · Cited by 23
Finfer, S. R. (2013) · Virulence · doi:10.4161/viru.25855 · Cited by 21
Ichaï, C., Cariou, A., Léone, M., Veber, B., & Barnoud, D. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.06.001 · Cited by 20
“Ainsi, la prise en compte des nouvelles données [2-7] a conduit à reformuler six recommandations émanant des chapitres sur « Le contrôle glycémique en réanimation » et « La réalisation pratique des apports glucidiques » comme suit.”
BackgroundsRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy
Arabi, Y. M., Dehbi, M., Rishu, A. H., Baturcam, E., Kahoul, S. H., Brits, R. J., Naidu, B., & Bouchama, A. (2011) · Critical Care · doi:10.1186/cc10420 · Cited by 20
“They were not included if they had type I diabetes, diabetic ketoacidosis, documented hypoglycemia on ICU admission or in the same hospitalization, brain death, do-not-resuscitate status, terminal illness defined as expected survival of less than four weeks as judged by the treating physician, post cardiac arrest, sei…”
BackgroundMethodSelf-citationSachwani, G. R., Jaehne, A. K., Jayaprakash, N., Kuzich, M., Onkoba, V., Blyden, D., & Rivers, E. P. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0122-7 · Cited by 24
Inpatient dysglycemia and clinical outcomes: Association or causation?
Umpierrez, G. E., & Kosiborod, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.008 · Cited by 22
“The authors report a rate of severe hypoglycemia between 5% and 28.6% in ICU trials (Arabi et al., 2008; Finfer et al., 2009; Griesdale et al., 2009; van den Berghe et al., 2001; Van den Berghe et al., 2006) and 5% and 32% in non-ICU patients treated with subcutaneous insulin (Umpierrez et al.,…”
BackgroundInfluentialDrazen, J. M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1207121 · Cited by 21
Uijtendaal, E. V., Rijkom, J. E. F. Z., de Lange, D. W., Lalmohamed, A., van Solinge, W. W., & Egberts, T. C. G. (2015) · Critical Care · doi:10.1186/s13054-015-0959-9 · Cited by 20
“This percentage compares favourably to the percentages 5.1 – 28.6 % found in other studies [8, 11, 15].”
InfluentialThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Kerry, C., Mitchell, S., Sharma, S., Scott, A., & Rayman, G. A. (2013) · Diabetic Medicine · doi:10.1111/dme.12256 · Cited by 21
Okada, T., Kawahito, S., Mita, N., Matsuhisa, M., Kitahata, H., Shimada, M., & Oshita, S. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.205 · Cited by 18
Cerebral Metabolism and the Role of Glucose Control in Acute Traumatic Brain Injury
Blanco, M. M. B., Prashant, G. N., & Vespa, P. M. (2016) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2016.05.003 · Cited by 21
Sato, H., Carvalho, G., Sato, T., Bracco, D., Codère-Maruyama, T., Lattermann, R., Hatzakorzian, R., Matsukawa, T., & Schricker, T. (2010) · Nutrition · doi:10.1016/j.nut.2009.10.005 · Cited by 21
Plummer, M. P., Notkina, N., Timofeev, I. S., Hutchinson, P. J., Finnis, M., & Gupta, A. K. (2018) · Critical Care · doi:10.1186/s13054-017-1933-5 · Cited by 21
Glycemic control in critically ill patients: What to do post NICE-SUGAR?
Marik, P. E. (2009) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v1.i1.3 · Cited by 19
Intensive insulin therapy during cardiovascular surgery
Kawahito, S., Kitahata, H., Kitagawa, T., & Oshita, S. (2010) · The Journal of Medical Investigation · doi:10.2152/jmi.57.191 · Cited by 18
Treatment of Endocrine Disorders in the Neuroscience Intensive Care Unit
Hwang, J. J., & Hwang, D. Y. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0271-4 · Cited by 19
Wintergerst, K. A., Foster, M. B., Sullivan, J. E., & Woods, C. R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600102 · Cited by 18
Azarfarin, R., Sheikhzadeh, D., Mirinazhad, M., Bilehjani, E., & Alizadehasl, A. (2011) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2011.05.009 · Cited by 17
Incidence of Hypoglycemia with Tight Glycemic Control Protocols: A Comparative Study
Anabtawi, A., Hurst, M., Titi, M. A., Patel, S. R., Palacio, C., & Rajamani, K. K. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0009 · Cited by 16
Hersh, A. M., Hirshberg, E. L., Wilson, E. L., Orme, J. F., Morris, A. H., & Lanspa, M. J. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.04.025 · Cited by 18
Metadata
- Authors
- Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., Kahoul, S. H., Britts, R. J., & Sakkijha, M. H.
- Affiliations
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Venue
- Critical Care Medicine
- Published
- 2008-12
- Volume
- 36
- Issue
- 12
- Pages
- 3190-3197
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2058406121
- Cited by
- 471
- References
- 27
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 19 · 2019: 21 · 2018: 23 · 2017: 23 · 2016: 32 · 2015: 39 · 2014: 25 · 2013: 28 · 2012: 41
- FWCI
- 40.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, conventional insulin therapy, glycemic control, critically ill patients, ICU mortality, hypoglycemia, glycemic targets, mechanical ventilation, renal replacement therapy, intensive care unit infections, length of hospital stay, hyperglycemia, sepsis, trauma, neurocritical care
- MeSH terms
- Blood Glucose, Body Weights and Measures, Demography, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Length of Stay, Male, Middle Aged, Postoperative Period, Respiration, Artificial, Surgical Procedures, Operative, Critical Illness, Hospital Mortality, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.